Inhibition/NN
of/IN
anti-CD3/JJ
monoclonal/JJ
antibody-induced/JJ
T-cell/NN
proliferation/NN
by/IN
dexamethasone/NN
,/,
isoproterenol/NN
,/,
or/CC
prostaglandin/NN
E2/NN
either/CC
alone/RB
or/CC
in/IN
combination/NN
./.

1/LS
./.
=====
The/DT
purpose/NN
of/IN
these/DT
studies/NNS
was/VBD
to/TO
investigate/VB
the/DT
modulation/NN
of/IN
the/DT
proliferation/NN
of/IN
human/JJ
T/NN
cells/NNS
obtained/VBN
from/IN
peripheral/JJ
blood/NN
by/IN
dexamethasone/NN
(/(
DEX/NN
)/)
,/,
isoproterenol/NN
(/(
ISO/NN
)/)
,/,
and/CC
prostaglandin/NN
E2/NN
(/(
PGE2/NN
)/)
./.
=====
The/DT
former/JJ
two/CD
substances/NNS
interact/VBP
with/IN
T/NN
cells/NNS
via/IN
the/DT
glucocorticoid/NN
and/CC
beta-adrenergic/JJ
receptors/NNS
respectively/RB
./.
=====
When/WRB
occupied/VBN
by/IN
their/PRP$
natural/JJ
ligands/NNS
,/,
glucocorticosteroids/NNS
and/CC
catecholamines/NNS
,/,
these/DT
receptors/NNS
have/VBP
a/DT
role/NN
in/IN
modulating/VBG
T-cell/NN
function/NN
during/IN
stress/NN
./.
=====
During/IN
the/DT
inflammatory/JJ
response/NN
increased/VBN
levels/NNS
of/IN
PGE2/NN
bind/VBP
to/TO
their/PRP$
receptors/NNS
on/IN
T/NN
cells/NNS
and/CC
thus/RB
alter/VBP
responsiveness/NN
./.
=====
Proliferation/NN
of/IN
T/NN
cells/NNS
was/VBD
induced/VBN
by/IN
immobilized/VBN
anti-CD3/JJ
monoclonal/JJ
antibody/NN
(/(
mAb/NN
)/)
in/IN
the/DT
presence/NN
or/CC
absence/NN
of/IN
an/DT
additional/JJ
costimulatory/JJ
signal/NN
delivered/VBN
by/IN
anti-CD28/JJ
mAb/NN
./.
=====
2/LS
./.
=====
Various/JJ
physiologic/JJ
concentrations/NNS
of/IN
DEX/NN
,/,
ISO/NN
,/,
or/CC
PGE2/NN
were/VBD
added/VBN
at/IN
the/DT
time/NN
of/IN
initiation/NN
of/IN
the/DT
cultures/NNS
and/CC
subsequent/JJ
proliferation/NN
of/IN
the/DT
unstimulated/JJ
T/NN
cells/NNS
was/VBD
determined/VBN
./.
=====
The/DT
results/NNS
demonstrate/VBP
that/IN
physiologic/JJ
concentrations/NNS
of/IN
all/DT
three/CD
of/IN
these/DT
agents/NNS
inhibit/VBP
the/DT
anti-CD3/JJ
mAb-induced/JJ
proliferation/NN
of/IN
T/NN
cells/NNS
./.
=====
3/LS
./.
=====
Although/IN
DEX/NN
and/CC
PGE2/NN
were/VBD
equipotent/JJ
in/IN
suppressing/JJ
T-cell/NN
proliferation/NN
,/,
ISO/NN
was/VBD
much/RB
less/RBR
effective/JJ
./.
=====
4/LS
./.
=====
Because/IN
concomitant/JJ
elevations/NNS
in/IN
the/DT
peripheral/JJ
levels/NNS
of/IN
these/DT
substances/NNS
may/MD
occur/VB
,/,
experiments/NNS
were/VBD
performed/VBN
to/TO
determine/VB
the/DT
T-cell/NN
inhibitory/JJ
effects/NNS
of/IN
DEX/NN
together/RB
with/IN
either/CC
PGE2/NN
or/CC
ISO/NN
./.
=====
Synergistic/JJ
suppression/NN
of/IN
T-cell/NN
proliferation/NN
was/VBD
observed/VBN
when/WRB
various/JJ
concentrations/NNS
of/IN
DEX/NN
and/CC
PGE2/NN
,/,
but/CC
not/RB
DEX/NN
and/CC
ISO/NN
,/,
were/VBD
added/VBN
to/TO
cultures/NNS
./.
=====
This/DT
synergistic/JJ
suppression/NN
could/MD
not/RB
be/VB
explained/VBN
by/IN
an/DT
increase/NN
in/IN
cAMP/NN
accumulation/NN
in/IN
T/NN
cells/NNS
stimulated/VBN
with/IN
DEX/NN
and/CC
PGE2/NN
./.
=====
5/LS
./.
=====
Finally/RB
,/,
the/DT
addition/NN
of/IN
anti-CD28/JJ
mAb/NN
to/TO
anti-CD3/JJ
mAb-stimulated/JJ
T/NN
cells/NNS
overcame/VBD
much/JJ
of/IN
the/DT
suppression/NN
of/IN
proliferation/NN
induced/VBN
by/IN
PGE2/NN
or/CC
ISO/NN
but/CC
less/RBR
so/RB
than/IN
that/DT
induced/VBN
by/IN
DEX/NN
./.